Company: IMXI
Filing Date: 2025-11-05
Form Type: DEFM14A
Source: 0001140361-25-040538
Chunk: 115

Company: International Money Express, Inc.
Filing Date: 2025-11-05
Form: DEFM14A
Chunk 115
---
,776 |
| Andras Bende           |     |       68,189 |     |         1,091,024 |
| Joseph Aguilar         |     |       71,959 |     |         1,151,344 |
| Christopher Hunt       |     |       27,537 |     |           440,592 |
| Robert Pargac          |     |       18,445 |     |           295,120 |
| Non-Employee Directors |     |              |     |                   |
| Debra Bradford         |     |       24,408 |     |           390,528 |
| Bernardo Fernández     |     |       23,606 |     |           377,696 |
| Adam Godfrey           |     |       92,164 |     |         1,474,624 |
| Karen Higgins-Carter   |     |       11,064 |     |           177,024 |
| Laura Maydón           |     |       33,093 |     |           529,488 |
| Michael Purcell        |     |       68,624 |     |         1,097,984 |
| John Rincon            |     |      300,588 |     |         4,809,408 |

Treatment of Equity-Based Awards Company Options The Merger Agreement provides that at the Effective Time, each Company Option that is outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, will be canceled and converted into the right to receive an amount in cash (without interest), rounded down to the nearest cent, equal to

67

TABLE OF CONTENTS

the product of (i) the aggregate number of shares of our common stock subject to such Company Option as of immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option. For clarity, each Company Option which is outstanding as of the Effective Time with an exercise price equal to or in excess of the Merger Consideration shall be cancelled without any payment at the Effective Time. The following table sets forth, for each individual who has been one of Intermex’s directors or executive officers at any time since the beginning of the last fiscal year (i) the number of vested and unvested Company Options that were held as of October 15, 2025 and (ii